Rick Doblin

So I think at the end of it, it could be that the groups do just as well as the individuals. And then that will dramatically reduce the cost of the treatment and help it scale. So that's where we're at this initial thing.

So I think at the end of it, it could be that the groups do just as well as the individuals. And then that will dramatically reduce the cost of the treatment and help it scale. So that's where we're at this initial thing.

And I think particularly for military people that are traumatized in similar circumstances, that are bonded in groups, that group therapy can maybe even be the treatment of choice. But I think the way the FDA is going to be reviewing it is that there is going to be studies with individuals first. That will have to be gone through the system and approved.

And I think particularly for military people that are traumatized in similar circumstances, that are bonded in groups, that group therapy can maybe even be the treatment of choice. But I think the way the FDA is going to be reviewing it is that there is going to be studies with individuals first. That will have to be gone through the system and approved.

And I think particularly for military people that are traumatized in similar circumstances, that are bonded in groups, that group therapy can maybe even be the treatment of choice. But I think the way the FDA is going to be reviewing it is that there is going to be studies with individuals first. That will have to be gone through the system and approved.

And then there will be this additional research with groups.

And then there will be this additional research with groups.

And then there will be this additional research with groups.

Well, it's going to be about three years for the project in Israel. I mean, it's going to be about 160 people.

Well, it's going to be about three years for the project in Israel. I mean, it's going to be about 160 people.

Well, it's going to be about three years for the project in Israel. I mean, it's going to be about 160 people.

The project at the Portland, Oregon VA is going to be done pretty soon, but it's really just been four or five cohorts. It's very small numbers of people, and so there will need to be more. I think that there's been some efforts to do what people call in some ways a modified version of individual versus group, is that

The project at the Portland, Oregon VA is going to be done pretty soon, but it's really just been four or five cohorts. It's very small numbers of people, and so there will need to be more. I think that there's been some efforts to do what people call in some ways a modified version of individual versus group, is that

The project at the Portland, Oregon VA is going to be done pretty soon, but it's really just been four or five cohorts. It's very small numbers of people, and so there will need to be more. I think that there's been some efforts to do what people call in some ways a modified version of individual versus group, is that

And they've done some of this at Sunstone also, where there'll be four people getting psilocybin at the same time, but each in a separate room, each with one therapist. But then near the end of the session, they bring them together, and then they talk about what happened, and then they also have the group integration. So it's kind of a modified process.

And they've done some of this at Sunstone also, where there'll be four people getting psilocybin at the same time, but each in a separate room, each with one therapist. But then near the end of the session, they bring them together, and then they talk about what happened, and then they also have the group integration. So it's kind of a modified process.

And they've done some of this at Sunstone also, where there'll be four people getting psilocybin at the same time, but each in a separate room, each with one therapist. But then near the end of the session, they bring them together, and then they talk about what happened, and then they also have the group integration. So it's kind of a modified process.

So I think in terms of timeframe, it's probably four or five years before FDA will approve group therapy, maybe longer. The other issue is that the last time that we spoke, it was before the FDA advisory committee and before the FDA meeting to decide whether to approve MDMA-assisted therapy for PTSD. And the advisory committee recommended against it, and the FDA voted against it.

So I think in terms of timeframe, it's probably four or five years before FDA will approve group therapy, maybe longer. The other issue is that the last time that we spoke, it was before the FDA advisory committee and before the FDA meeting to decide whether to approve MDMA-assisted therapy for PTSD. And the advisory committee recommended against it, and the FDA voted against it.

So I think in terms of timeframe, it's probably four or five years before FDA will approve group therapy, maybe longer. The other issue is that the last time that we spoke, it was before the FDA advisory committee and before the FDA meeting to decide whether to approve MDMA-assisted therapy for PTSD. And the advisory committee recommended against it, and the FDA voted against it.